BOSTON--(BUSINESS WIRE)--Oct. 28, 2015--
to Tweet this News
Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is
developing innovative and proprietary treatments for exercise-associated
muscle cramps, nocturnal leg cramps and spasms associated with severe
neuromuscular conditions, today announced that it will report its
financial results for the quarter ended September 30, 2015 on Wednesday,
November 4, 2015 before the U.S. financial markets open. The Company
will host a conference call and webcast at 9:00 a.m. ET to discuss third
quarter 2015 financial results and provide a business update.
Individuals interested in participating in the call should dial (855)
780-7202 (U.S. and Canada) or (631) 485-4874 (International), Conference
A live webcast may be accessed in the Investors section of the Company's
website at www.flex-pharma.com.
Please log on to the Flex Pharma website approximately 15 minutes prior
to the scheduled webcast to ensure adequate time for any software
downloads that may be required. A replay of the webcast will be
available on Flex Pharma's website for three months.
About Flex Pharma
Flex Pharma, Inc. is a biotechnology company that is developing
innovative and proprietary treatments for exercise-associated muscle
cramps, nocturnal leg cramps, and spasms associated with severe
neuromuscular conditions. In three randomized, blinded,
placebo-controlled, cross-over studies, Flex Pharma's proprietary
treatment has shown a statistically significant reduction in the
intensity of muscle cramps in healthy normal volunteers.
Flex Pharma was founded by National Academy of Sciences members Rod
MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized
leaders in the fields of ion channels and neurobiology, along with
Chairman and Chief Executive Officer, Christoph Westphal, M.D., Ph.D.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151028005137/en/
Source: Flex Pharma, Inc.
Flex Pharma, Inc.
Elizabeth Woo, 617-874-1829
Relations & Corporate Communications